CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Hemispherx Biopharma

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. Its products include Ampligen, which is under clinical development for the treatment of Chronic Fatigue Syndrome, Hepatitis B, human immunodeficiency virus (HIV), renal cell carcinoma, and malignant melanoma; Alferon N Injection, an injectable formulation of natural alpha interferon for the treatment of certain categories of genital warts; and Alferon LDO, a low-dose oral liquid formulation of natural alpha interferon for the treatment of influenza and other emerging viral diseases. Hemispherx Biopharma, Inc. was founded in 1990 and is headquartered in Philadelphia, Pennsylvania.

Arbor Hospice and Home Care

Arbor Hospice and Home Care is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Ann Arbor, MI. To find more information about Arbor Hospice and Home Care, please visit www.arborhospice.org

Carefor Health and Community Services

Since 1897, Carefor® Health & Community Services, a registered charity, has been keeping families together longer at home by providing home health care and community support services.

Medisafe

Medisafe® is the leading Personalized Medication Management Platform helping patients stay on top of all their medications. Way more than a pill organizer (although it`s that, too), Medisafe makes it easy to adhere to the most complicated medication schedule, so wondering, “Did I take this already?” is a thing of the past. But that`s just the beginning. Medisafe connects users to their family (and soon, their doctors) for support, encouragement and expertise. It learns about each user`s unique situation, so it can deliver custom notifications for appointments and refills, medication updates, personalized health recommendations and discounts to help you stay organized, informed and on budget. And it tracks progress correlated with measurements like blood pressure and glucose levels to show the direct health benefit of taking meds as prescribed. By addressing all the major root causes for failing to take medications as prescribed, Medisafe improves patient satisfaction and quality of care and eliminates admissions and outpatient visits resulting from incorrect or missed doses. Medisafe arms providers and payers with information about patient compliance and related behaviors, so they can focus on the most pressing situations at any time. Understanding which patients are most at risk (and threatening to add avoidable strain to an overburdened healthcare system) helps all stakeholders in the care continuum use limited time and resources as efficiently as possible. Medisafe currently has more than 7 million users across iOS and Android smartphones and tablets, who have recorded over 4 billion medication doses taken correctly. Nearly 250,000 users have rated the app an average of 4.6 out of 5 stars in the iTunes and Google Play app stores.

GSI Health

GSI Health is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.